PARK DENTAL PARTNERS INC (PARK)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$20.43-0.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · PARK
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 37.3% |
| Our one-year growth estimate | diamond | 88.7% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 51.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 27 industry peers · Company calendar date is not available
PARK — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-08-10
Unregistered Sales of Equity Securities. The information set forth in
Why it matters: If revenue growth picks up, it could benefit PARK as the sector matures.
Supportive ifHealth care revenue growth re-accelerates back toward its highs, above 10%.
Worry ifRevenue growth is slowing down. It is now below 10%.
Why it matters: A steady margin shows good cost control and efficient operations.
Supportive ifAdjusted EBITDA margin for Q2 2026 was above 8.3%.
Worry ifAdjusted EBITDA margin for Q2 2026 was below 8.3%.
Why it matters: Confirming other revenue guidance shows stability in extra revenue sources. This is important for growth.
Supportive ifQ2 other revenue meets or exceeds $21M, supporting the fiscal 2026 range of $21M to $23M.
Worry ifQ2 other revenue is below $21M. This hints at possible problems with non-core revenue.
Why it matters: Closing this deal would expand Park Dental into North Carolina and add 48 doctors. This supports growth and market presence.
Supportive ifThe deal will close on time. There will be no delays or extra conditions.
Worry ifThe acquisition has big regulatory problems or does not close by year-end.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$199 on $10,000 · ±2.0% | How much price usually moves either way. |
| Bad day | $639 loss on $10,000 · 6.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,328 loss on $10,000 · 23.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: This growth rate is key to meeting the full-year revenue outlook. A drop would signal challenges in maintaining growth.
Worry ifQ2 revenue growth lands below 4.7% year over year.
Less concerning ifQ2 revenue growth exceeds 4.7% year over year.
Why it matters: Confirming revenue guidance shows the company is on track to meet its goals. It helps investors gauge growth stability.
Supportive ifQ2 revenue meets or exceeds $62.5M, supporting the fiscal 2026 range of $254M to $258M.
Worry ifQ2 revenue is under $62.5M. This shows possible problems in hitting the yearly goal.
Why it matters: This growth rate shows strong performance. It helps the revenue outlook for fiscal 2026.
Supportive ifSame-practice revenue growth exceeds 3.5% in Q3.
Worry ifSame-practice revenue growth falls below 3.5% in Q3.
Why it matters: Keeping this growth rate shows strong patient demand and good integration of acquisitions.
Supportive ifQ3 revenue growth is reported at 5% or higher year over year.
Worry ifQ3 revenue growth falls below 3% year over year.
Why it matters: Better margins mean lower costs and more efficient work.
Supportive ifGross margin percentage improves to at least 15% in Q3.
Worry ifGross margin percentage declines further below 14% in Q3.
Why it matters: A high retention rate shows strong patient satisfaction and loyalty, which is key for growth.
Supportive ifPatient retention rate reported above 90% for Q3.
Worry ifPatient retention rate falls below 88% for Q3.